EBOS GROUP LIMITED — Director's Dealing 2016

Sep 26, 2016

==> picture [98 x 27] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		27-Sep-16
Date of last disclosure:		N/A
Director or senior manager giving disclosure
Full name(s):		Brett Barons
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		Executive General Manager,Pharmacy
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class ofaffected quotedfinancialproducts:		Ordinaryshares in EBOS GroupLimited
Nature of the affected relevant interest(s):
		Issue of shares pursuant to loan funded long
		term incentive plan. While the shares are
		issued and held in the executive's name the
		shares will not vest unless and until
		performance conditions are met. The
		performance conditions will be tested after
		the end of the performance period, being 1
		July 2016 to 30 June 2019. The executive
		cannot deal in the shares unless and until
		those shares vest.
For that relevant interest-
Number held in class before acquisition or disposal:		N/A
Number held in class after acquisition or disposal:		55,000 ordinaryshares
Current registered holder(s):		N/A
Registeredholder(s) once transfers areregistered:		Brett Barons

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		27-Sep-16
Date of last disclosure:		N/A
Director or senior manager giving disclosure
Full name(s):		Brett Barons
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		Executive General Manager,Pharmacy
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class ofaffected quotedfinancialproducts:		Ordinaryshares in EBOS GroupLimited
Nature of the affected relevant interest(s):		Issue of shares pursuant to loan funded long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2016 to 30 June 2019. The executive cannot deal in the shares unless and until those shares vest.
For that relevant interest-
Number held in class before acquisition or disposal:		N/A
Number held in class after acquisition or disposal:		55,000 ordinaryshares
Current registered holder(s):		N/A
Registeredholder(s) once transfers areregistered:		Brett Barons
Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab		le)
Type of affected derivative:		N/A
Class of underlyingfinancialproducts:		N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial products(if any):		N/A
A statement as to whether the derivative is cash settled orphysicallysettled:		N/A
Maturitydate of the derivative(if any):		N/A
Expirydate of the derivative(if any):		N/A
Theprice specified in the terms of the derivative(if any):		N/A
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts:		N/A
_For that derivative,- _
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative:		N/A
Details of transactions giving rise to acquisition or disposal
Total numberoftransactions towhich noticerelates:		1
		27-Sep-16

Nature of transaction:		Issue of shares pursuant to loan funded long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2016 to 30 June 2019. The executive cannot deal in the shares unless and until those shares vest.
Name ofany otherparty orparties to the transaction(if known):		N/A
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration:		$998,250.00
Numberof financialproducts towhichthe transaction related:		55,000 ordinaryshares
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details—
Whether relevantinterestswere acquired ordisposed ofduring a closed period:		No
Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod:		N/A
Date of theprior written clearance(if any):		N/A
Summary of other relevant interests after acquisition or disposal: Class ofquotedfinancialproducts: Nature of relevant interest: For that relevant interest,- Number heldinclass: Currentregisteredholder(s): For a derivative relevant interest,- Type ofderivative: Details of derivative,-
		N/A
		N/A
		N/A
		N/A
		N/A
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):		N/A
A statement as to whether the derivative is cash settled or physically settled:		N/A
Maturity date of the derivative (if any):		N/A
Expiry date of the derivative (if any):		N/A
The price's specified terms (if any):		N/A
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts:		N/A
For that derivative relevant interest,-		N/A
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:		N/A

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer:

Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:

==> picture [75 x 17] intentionally omitted <==

27-Sep-16 Janelle Cain, General Counsel, EBOS Group Limited

==> picture [98 x 27] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		27-Sep-16
Date of last disclosure:		19-Nov-15
Director or senior manager giving disclosure
Full name(s):		Michael Broome
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		Group General Manager, HCL & Symbion
		Contract Logistics
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class ofaffected quotedfinancialproducts:		Ordinaryshares in EBOS GroupLimited
Nature of the affected relevant interest(s):
		Issue of shares pursuant to loan funded long
		term incentive plan. While the shares are
		issued and held in the executive's name the
		shares will not vest unless and until
		performance conditions are met. The
		performance conditions will be tested after
		the end of the performance period, being 1
		July 2016 to 30 June 2019. The executive
		cannot deal in the shares unless and until
		those shares vest.
For that relevant interest-
Number held in class before acquisition or disposal:		N/A
Number held in class after acquisition or disposal:		40,000 ordinaryshares
Current registered holder(s):		N/A
Registeredholder(s) once transfers areregistered:		Michael Broome

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		27-Sep-16
Date of last disclosure:		19-Nov-15
Director or senior manager giving disclosure
Full name(s):		Michael Broome
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		Group General Manager, HCL & Symbion Contract Logistics
Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest-
Class ofaffected quotedfinancialproducts:		Ordinaryshares in EBOS GroupLimited
Nature of the affected relevant interest(s):		Issue of shares pursuant to loan funded long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2016 to 30 June 2019. The executive cannot deal in the shares unless and until those shares vest.
For that relevant interest-
Number held in class before acquisition or disposal:		N/A
Number held in class after acquisition or disposal:		40,000 ordinaryshares
Current registered holder(s):		N/A
Registeredholder(s) once transfers areregistered:		Michael Broome
Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab		le)
Type of affected derivative:		N/A
Class of underlyingfinancialproducts:		N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial products(if any):		N/A
A statement as to whether the derivative is cash settled orphysicallysettled:		N/A
Maturitydate of the derivative(if any):		N/A
Expirydate of the derivative(if any):		N/A
Theprice specified in the terms of the derivative(if any):		N/A
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts:		N/A
_For that derivative,- _
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative:		N/A
Details of transactions giving rise to acquisition or disposal
Total numberoftransactions towhich noticerelates:		1
		27-Sep-16

==> picture [75 x 7] intentionally omitted <==

----- Start of picture text -----

Nature of transaction:
----- End of picture text -----

Issue of shares pursuant to loan funded long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2016 to 30 June 2019. The executive cannot deal in the shares unless and until those shares vest. Name of any other party or parties to the transaction (if known): N/A The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: $726,000.00 Number of financial products to which the transaction related: 40,000 ordinary shares If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— Whether relevant interests were acquired or disposed of during a closed period: No Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: N/A Date of the prior written clearance (if any): N/A Summary of other relevant interests after acquisition or disposal: Class of quoted financial products: Ordinary shares Nature of relevant interest: Directly held For that relevant interest,- Number held in class: 1,712 Current registered holder(s): Michael Wynston Broome For a derivative relevant interest,- Type of derivative: N/A Details of derivative,- N/A The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: N/A Maturity date of the derivative (if any): N/A Expiry date of the derivative (if any): N/A The price's specified terms (if any): N/A Any other details needed to understand how the amount of the consideration payable N/A under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- N/A Parties to the derivative: N/A If the director or senior manager is not a party to the derivative, the nature of the relevant N/A interest in the derivative:

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:

==> picture [75 x 17] intentionally omitted <==

27-Sep-16 Janelle Cain, General Counsel, EBOS Group Limited

==> picture [98 x 27] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		27-Sep-16
Date of last disclosure:		N/A
Director or senior manager giving disclosure
Full name(s):		Simon Bunde
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		General Manager, Group Operations & Strategy
Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest-
Class ofaffected quotedfinancialproducts:		Ordinaryshares in EBOS GroupLimited
Nature of the affected relevant interest(s):		Issue of shares pursuant to loan funded long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2016 to 30 June 2019. The executive cannot deal in the shares unless and until those shares vest.
For that relevant interest-
Number held in class before acquisition or disposal:		N/A
Number held in class after acquisition or disposal:		35,000 ordinaryshares
Current registered holder(s):		N/A
Registeredholder(s) once transfers areregistered:		Simon Bunde

Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab	Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab	le)
Type of affected derivative:		N/A
Class of underlyingfinancialproducts:		N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial products(if any):		N/A
A statement as to whether the derivative is cash settled orphysicallysettled:		N/A
Maturitydate of the derivative(if any):		N/A
Expirydate of the derivative(if any):		N/A
Theprice specified in the terms of the derivative(if any):		N/A
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts:		N/A
_For that derivative,- _
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative:		N/A
Details of transactions giving rise to acquisition or disposal
Total numberoftransactions towhich noticerelates:		1
		27-Sep-16

Nature of transaction:		Issue of shares pursuant to loan funded long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2016 to 30 June 2019. The executive cannot deal in the shares unless and until those shares vest.
Name ofany otherparty orparties to the transaction(if known):		N/A
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration:		$635,250.00
Numberof financialproducts towhichthe transaction related:		35,000 ordinaryshares
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details—
Whether relevantinterestswere acquired ordisposed ofduring a closed period:		No
Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod:		N/A
Date of theprior written clearance(if any):		N/A
Summary of other relevant interests after acquisition or disposal: Class ofquotedfinancialproducts: Nature of relevant interest: For that relevant interest,- Number heldinclass: Currentregisteredholder(s): For a derivative relevant interest,- Type ofderivative: Details of derivative,-
		N/A
		N/A
		N/A
		N/A
		N/A
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):		N/A
A statement as to whether the derivative is cash settled or physically settled:		N/A
Maturity date of the derivative (if any):		N/A
Expiry date of the derivative (if any):		N/A
The price's specified terms (if any):		N/A
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts:		N/A
For that derivative relevant interest,-		N/A
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:		N/A

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer:

Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:

==> picture [75 x 17] intentionally omitted <==

27-Sep-16 Janelle Cain, General Counsel, EBOS Group Limited

==> picture [98 x 27] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		27-Sep-16
Date of last disclosure:		N/A
Director or senior manager giving disclosure
Full name(s):		John Cullity
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		Chief Financial Officer
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class ofaffected quotedfinancialproducts:		Ordinaryshares in EBOS GroupLimited
Nature of the affected relevant interest(s):
		Issue of shares pursuant to loan funded long
		term incentive plan. While the shares are
		issued and held in the executive's name the
		shares will not vest unless and until
		performance conditions are met. The
		performance conditions will be tested after
		the end of the performance period, being 1
		July 2016 to 30 June 2019. The executive
		cannot deal in the shares unless and until
		those shares vest.
For that relevant interest-
Number held in class before acquisition or disposal:		N/A
Number held in class after acquisition or disposal:		95,000 ordinaryshares
Current registered holder(s):		N/A
Registeredholder(s) once transfers areregistered:		John Cullity

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		27-Sep-16
Date of last disclosure:		N/A
Director or senior manager giving disclosure
Full name(s):		John Cullity
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		Chief Financial Officer
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class ofaffected quotedfinancialproducts:		Ordinaryshares in EBOS GroupLimited
Nature of the affected relevant interest(s):		Issue of shares pursuant to loan funded long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2016 to 30 June 2019. The executive cannot deal in the shares unless and until those shares vest.
For that relevant interest-
Number held in class before acquisition or disposal:		N/A
Number held in class after acquisition or disposal:		95,000 ordinaryshares
Current registered holder(s):		N/A
Registeredholder(s) once transfers areregistered:		John Cullity
Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab		le)
Type of affected derivative:		N/A
Class of underlyingfinancialproducts:		N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial products(if any):		N/A
A statement as to whether the derivative is cash settled orphysicallysettled:		N/A
Maturitydate of the derivative(if any):		N/A
Expirydate of the derivative(if any):		N/A
Theprice specified in the terms of the derivative(if any):		N/A
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts:		N/A
_For that derivative,- _
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative:		N/A
Details of transactions giving rise to acquisition or disposal
Total numberoftransactions towhich noticerelates:		1
		27-Sep-16

Nature of transaction:		Issue of shares pursuant to loan funded long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2016 to 30 June 2019. The executive cannot deal in the shares unless and until those shares vest.
Name ofany otherparty orparties to the transaction(if known):		N/A
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration:		$1,724,250.00
Numberof financialproducts towhichthe transaction related:		95,000 ordinaryshares
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details—
Whether relevantinterestswere acquired ordisposed ofduring a closed period:		No
Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod:		N/A
Date of theprior written clearance(if any):		N/A
Summary of other relevant interests after acquisition or disposal: Class ofquotedfinancialproducts: Nature of relevant interest: For that relevant interest,- Number heldinclass: Currentregisteredholder(s): For a derivative relevant interest,- Type ofderivative: Details of derivative,-
		N/A
		N/A
		N/A
		N/A
		N/A
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):		N/A
A statement as to whether the derivative is cash settled or physically settled:		N/A
Maturity date of the derivative (if any):		N/A
Expiry date of the derivative (if any):		N/A
The price's specified terms (if any):		N/A
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts:		N/A
For that derivative relevant interest,-		N/A
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:		N/A

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer:

Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:

==> picture [75 x 17] intentionally omitted <==

27-Sep-16 Janelle Cain, General Counsel, EBOS Group Limited

==> picture [98 x 27] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		27-Sep-16
Date of last disclosure:		19-Nov-15
Director or senior manager giving disclosure
Full name(s):		Patrick Davies
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		Chief Executive Officer
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class ofaffected quotedfinancialproducts:		Ordinaryshares in EBOS GroupLimited
Nature of the affected relevant interest(s):
		Issue of shares pursuant to loan funded long
		term incentive plan. While the shares are
		issued and held in the executive's name the
		shares will not vest unless and until
		performance conditions are met. The
		performance conditions will be tested after
		the end of the performance period, being 1
		July 2016 to 30 June 2019. The executive
		cannot deal in the shares unless and until
		those shares vest.
For that relevant interest-
Number held in class before acquisition or disposal:		Nil
Number held in class after acquisition or disposal:		210,000 ordinaryshares
Current registered holder(s):		N/A
Registeredholder(s) once transfers areregistered:		Patrick Davies

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		27-Sep-16
Date of last disclosure:		19-Nov-15
Director or senior manager giving disclosure
Full name(s):		Patrick Davies
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		Chief Executive Officer
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class ofaffected quotedfinancialproducts:		Ordinaryshares in EBOS GroupLimited
Nature of the affected relevant interest(s):		Issue of shares pursuant to loan funded long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2016 to 30 June 2019. The executive cannot deal in the shares unless and until those shares vest.
For that relevant interest-
Number held in class before acquisition or disposal:		Nil
Number held in class after acquisition or disposal:		210,000 ordinaryshares
Current registered holder(s):		N/A
Registeredholder(s) once transfers areregistered:		Patrick Davies
Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab		le)
Type of affected derivative:		N/A
Class of underlyingfinancialproducts:		N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial products(if any):		N/A
A statement as to whether the derivative is cash settled orphysicallysettled:		N/A
Maturitydate of the derivative(if any):		N/A
Expirydate of the derivative(if any):		N/A
Theprice specified in the terms of the derivative(if any):		N/A
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts:		N/A
_For that derivative,- _
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative:		N/A
Details of transactions giving rise to acquisition or disposal
Total numberoftransactions towhich noticerelates:		1
		27-Sep-16

Nature of transaction:		Issue of shares pursuant to loan funded long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2016 to 30 June 2019. The executive cannot deal in the shares unless and until those shares vest.	Issue of shares pursuant to loan funded long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2016 to 30 June 2019. The executive cannot deal in the shares unless and until those shares vest.
Name ofany otherparty orparties to the transaction(if known):		N/A
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration:		$3,811,500.00
Numberof financialproducts towhichthe transaction related:		210,000 ordinaryshares
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details—
Whether relevantinterestswere acquired ordisposed ofduring a closed period:		No
Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod:		N/A
Date of theprior written clearance(if any):		N/A
Summary of other relevant interests after acquisition or disposal: Class ofquotedfinancialproducts: Nature of relevant interest: For that relevant interest,- Number heldinclass: Currentregisteredholder(s): For a derivative relevant interest,- Type ofderivative: Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):		N/A
A statement as to whether the derivative is cash settled or physically settled:		N/A
Maturity date of the derivative (if any):		N/A
Expiry date of the derivative (if any):		N/A
The price's specified terms (if any):		N/A
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts:		N/A
For that derivative relevant interest,-		N/A
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:		N/A

Certification I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: 27-Sep-16

Name and title of authorised person:

Janelle Cain, General Counsel, EBOS Group Limited

==> picture [98 x 27] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		27-Sep-16
Date of last disclosure:		N/A
Director or senior manager giving disclosure
Full name(s):		Sean Duggan
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		Chief Executive Officer,Animal Care
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class ofaffected quotedfinancialproducts:		Ordinaryshares in EBOS GroupLimited
Nature of the affected relevant interest(s):
		Issue of shares pursuant to loan funded long
		term incentive plan. While the shares are
		issued and held in the executive's name the
		shares will not vest unless and until
		performance conditions are met. The
		performance conditions will be tested after
		the end of the performance period, being 1
		July 2016 to 30 June 2019. The executive
		cannot deal in the shares unless and until
		those shares vest.
For that relevant interest-
Number held in class before acquisition or disposal:		N/A
Number held in class after acquisition or disposal:		45,000 ordinaryshares
Current registered holder(s):		N/A
Registeredholder(s) once transfers areregistered:		Sean Duggan

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		27-Sep-16
Date of last disclosure:		N/A
Director or senior manager giving disclosure
Full name(s):		Sean Duggan
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		Chief Executive Officer,Animal Care
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class ofaffected quotedfinancialproducts:		Ordinaryshares in EBOS GroupLimited
Nature of the affected relevant interest(s):		Issue of shares pursuant to loan funded long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2016 to 30 June 2019. The executive cannot deal in the shares unless and until those shares vest.
For that relevant interest-
Number held in class before acquisition or disposal:		N/A
Number held in class after acquisition or disposal:		45,000 ordinaryshares
Current registered holder(s):		N/A
Registeredholder(s) once transfers areregistered:		Sean Duggan
Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab		le)
Type of affected derivative:		N/A
Class of underlyingfinancialproducts:		N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial products(if any):		N/A
A statement as to whether the derivative is cash settled orphysicallysettled:		N/A
Maturitydate of the derivative(if any):		N/A
Expirydate of the derivative(if any):		N/A
Theprice specified in the terms of the derivative(if any):		N/A
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts:		N/A
_For that derivative,- _
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative:		N/A
Details of transactions giving rise to acquisition or disposal
Total numberoftransactions towhich noticerelates:		1
		27-Sep-16

Nature of transaction:		Issue of shares pursuant to loan funded long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2016 to 30 June 2019. The executive cannot deal in the shares unless and until those shares vest.
Name ofany otherparty orparties to the transaction(if known):		N/A
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration:		$816,750.00
Numberof financialproducts towhichthe transaction related:		45,000 ordinaryshares
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details—
Whether relevantinterestswere acquired ordisposed ofduring a closed period:		No
Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod:		N/A
Date of theprior written clearance(if any):		N/A
Summary of other relevant interests after acquisition or disposal: Class ofquotedfinancialproducts: Nature of relevant interest: For that relevant interest,- Number heldinclass: Currentregisteredholder(s): For a derivative relevant interest,- Type ofderivative: Details of derivative,-
		N/A
		N/A
		N/A
		N/A
		N/A
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):		N/A
A statement as to whether the derivative is cash settled or physically settled:		N/A
Maturity date of the derivative (if any):		N/A
Expiry date of the derivative (if any):		N/A
The price's specified terms (if any):		N/A
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts:		N/A
For that derivative relevant interest,-		N/A
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:		N/A

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer:

Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:

==> picture [75 x 17] intentionally omitted <==

27-Sep-16 Janelle Cain, General Counsel, EBOS Group Limited

==> picture [98 x 27] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		27-Sep-16
Date of last disclosure:		9-Sep-16
Director or senior manager giving disclosure
Full name(s):		David Lewis
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		General Manager,Onelink Australia
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class ofaffected quotedfinancialproducts:		Ordinaryshares in EBOS GroupLimited
Nature of the affected relevant interest(s):
		Issue of shares pursuant to loan funded long
		term incentive plan. While the shares are
		issued and held in the executive's name the
		shares will not vest unless and until
		performance conditions are met. The
		performance conditions will be tested after
		the end of the performance period, being 1
		July 2016 to 30 June 2019. The executive
		cannot deal in the shares unless and until
		those shares vest.
For that relevant interest-
Number held in class before acquisition or disposal:		N/A
Number held in class after acquisition or disposal:		35,000 ordinaryshares
Current registered holder(s):		N/A
Registeredholder(s) once transfers areregistered:		David Lewis

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		27-Sep-16
Date of last disclosure:		9-Sep-16
Director or senior manager giving disclosure
Full name(s):		David Lewis
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		General Manager,Onelink Australia
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class ofaffected quotedfinancialproducts:		Ordinaryshares in EBOS GroupLimited
Nature of the affected relevant interest(s):		Issue of shares pursuant to loan funded long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2016 to 30 June 2019. The executive cannot deal in the shares unless and until those shares vest.
For that relevant interest-
Number held in class before acquisition or disposal:		N/A
Number held in class after acquisition or disposal:		35,000 ordinaryshares
Current registered holder(s):		N/A
Registeredholder(s) once transfers areregistered:		David Lewis
Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab		le)
Type of affected derivative:		N/A
Class of underlyingfinancialproducts:		N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial products(if any):		N/A
A statement as to whether the derivative is cash settled orphysicallysettled:		N/A
Maturitydate of the derivative(if any):		N/A
Expirydate of the derivative(if any):		N/A
Theprice specified in the terms of the derivative(if any):		N/A
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts:		N/A
_For that derivative,- _
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative:		N/A
Details of transactions giving rise to acquisition or disposal
Total numberoftransactions towhich noticerelates:		1
		27-Sep-16

Nature of transaction:		Issue of shares pursuant to loan funded long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2016 to 30 June 2019. The executive cannot deal in the shares unless and until those shares vest.
Name ofany otherparty orparties to the transaction(if known):		N/A
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration:		$635,250.00
Numberof financialproducts towhichthe transaction related:		35,000 ordinaryshares
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details—
Whether relevantinterestswere acquired ordisposed ofduring a closed period:		No
Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod:		N/A
Date of theprior written clearance(if any):		N/A
Summary of other relevant interests after acquisition or disposal: Class ofquotedfinancialproducts: Nature of relevant interest: For that relevant interest,- Number heldinclass: Currentregisteredholder(s): For a derivative relevant interest,- Type ofderivative: Details of derivative,-
		N/A
		N/A
		N/A
		N/A
		N/A
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):		N/A
A statement as to whether the derivative is cash settled or physically settled:		N/A
Maturity date of the derivative (if any):		N/A
Expiry date of the derivative (if any):		N/A
The price's specified terms (if any):		N/A
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts:		N/A
For that derivative relevant interest,-		N/A
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:		N/A

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer:

Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:

==> picture [75 x 17] intentionally omitted <==

27-Sep-16 Janelle Cain, General Counsel, EBOS Group Limited

==> picture [98 x 27] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		27-Sep-16
Date of last disclosure:		N/A
Director or senior manager giving disclosure
Full name(s):		Stuart Spencer
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		Executive General Manager, Institutional Healthcare
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class ofaffected quotedfinancialproducts:		Ordinaryshares in EBOS GroupLimited
Nature of the affected relevant interest(s):
		Issue of shares pursuant to loan funded long
		term incentive plan. While the shares are
		issued and held in the executive's name the
		shares will not vest unless and until
		performance conditions are met. The
		performance conditions will be tested after
		the end of the performance period, being 1
		July 2016 to 30 June 2019. The executive
		cannot deal in the shares unless and until
		those shares vest.
For that relevant interest-
Number held in class before acquisition or disposal:		N/A
Number held in class after acquisition or disposal:		45,000 ordinaryshares
Current registered holder(s):		N/A
Registeredholder(s) once transfers areregistered:		Stuart Spencer

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		27-Sep-16
Date of last disclosure:		N/A
Director or senior manager giving disclosure
Full name(s):		Stuart Spencer
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		Executive General Manager, Institutional Healthcare
Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest-
Class ofaffected quotedfinancialproducts:		Ordinaryshares in EBOS GroupLimited
Nature of the affected relevant interest(s):		Issue of shares pursuant to loan funded long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2016 to 30 June 2019. The executive cannot deal in the shares unless and until those shares vest.
For that relevant interest-
Number held in class before acquisition or disposal:		N/A
Number held in class after acquisition or disposal:		45,000 ordinaryshares
Current registered holder(s):		N/A
Registeredholder(s) once transfers areregistered:		Stuart Spencer
Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab		le)
Type of affected derivative:		N/A
Class of underlyingfinancialproducts:		N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial products(if any):		N/A
A statement as to whether the derivative is cash settled orphysicallysettled:		N/A
Maturitydate of the derivative(if any):		N/A
Expirydate of the derivative(if any):		N/A
Theprice specified in the terms of the derivative(if any):		N/A
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts:		N/A
_For that derivative,- _
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative:		N/A
Details of transactions giving rise to acquisition or disposal
Total numberoftransactions towhich noticerelates:		1
		27-Sep-16

Nature of transaction:		Issue of shares pursuant to loan funded long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2016 to 30 June 2019. The executive cannot deal in the shares unless and until those shares vest.
Name ofany otherparty orparties to the transaction(if known):		N/A
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration:		$816,750.00
Numberof financialproducts towhichthe transaction related:		45,000 ordinaryshares
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details—
Whether relevantinterestswere acquired ordisposed ofduring a closed period:		No
Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod:		N/A
Date of theprior written clearance(if any):		N/A
Summary of other relevant interests after acquisition or disposal: Class ofquotedfinancialproducts: Nature of relevant interest: For that relevant interest,- Number heldinclass: Currentregisteredholder(s): For a derivative relevant interest,- Type ofderivative: Details of derivative,-
		N/A
		N/A
		N/A
		N/A
		N/A
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):		N/A
A statement as to whether the derivative is cash settled or physically settled:		N/A
Maturity date of the derivative (if any):		N/A
Expiry date of the derivative (if any):		N/A
The price's specified terms (if any):		N/A
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts:		N/A
For that derivative relevant interest,-		N/A
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:		N/A

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer:

Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:

==> picture [75 x 17] intentionally omitted <==

27-Sep-16 Janelle Cain, General Counsel, EBOS Group Limited

==> picture [98 x 27] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		27-Sep-16
Date of last disclosure:		N/A
Director or senior manager giving disclosure
Full name(s):		Andrew Vidler
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		General Manager,Retail Services
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class ofaffected quotedfinancialproducts:		Ordinaryshares in EBOS GroupLimited
Nature of the affected relevant interest(s):
		Issue of shares pursuant to loan funded long
		term incentive plan. While the shares are
		issued and held in the executive's name the
		shares will not vest unless and until
		performance conditions are met. The
		performance conditions will be tested after
		the end of the performance period, being 1
		July 2016 to 30 June 2019. The executive
		cannot deal in the shares unless and until
		those shares vest.
For that relevant interest-
Number held in class before acquisition or disposal:		N/A
Number held in class after acquisition or disposal:		40,000 ordinaryshares
Current registered holder(s):		N/A
Registeredholder(s) once transfers areregistered:		Andrew Vidler

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		27-Sep-16
Date of last disclosure:		N/A
Director or senior manager giving disclosure
Full name(s):		Andrew Vidler
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		General Manager,Retail Services
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class ofaffected quotedfinancialproducts:		Ordinaryshares in EBOS GroupLimited
Nature of the affected relevant interest(s):		Issue of shares pursuant to loan funded long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2016 to 30 June 2019. The executive cannot deal in the shares unless and until those shares vest.
For that relevant interest-
Number held in class before acquisition or disposal:		N/A
Number held in class after acquisition or disposal:		40,000 ordinaryshares
Current registered holder(s):		N/A
Registeredholder(s) once transfers areregistered:		Andrew Vidler
Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab		le)
Type of affected derivative:		N/A
Class of underlyingfinancialproducts:		N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial products(if any):		N/A
A statement as to whether the derivative is cash settled orphysicallysettled:		N/A
Maturitydate of the derivative(if any):		N/A
Expirydate of the derivative(if any):		N/A
Theprice specified in the terms of the derivative(if any):		N/A
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts:		N/A
_For that derivative,- _
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative:		N/A
Details of transactions giving rise to acquisition or disposal
Total numberoftransactions towhich noticerelates:		1
		27-Sep-16

Nature of transaction:		Issue of shares pursuant to loan funded long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2016 to 30 June 2019. The executive cannot deal in the shares unless and until those shares vest.
Name ofany otherparty orparties to the transaction(if known):		N/A
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration:		$726,000.00
Numberof financialproducts towhichthe transaction related:		40,000 ordinaryshares
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details—
Whether relevantinterestswere acquired ordisposed ofduring a closed period:		No
Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod:		N/A
Date of theprior written clearance(if any):		N/A
Summary of other relevant interests after acquisition or disposal: Class ofquotedfinancialproducts: Nature of relevant interest: For that relevant interest,- Number heldinclass: Currentregisteredholder(s): For a derivative relevant interest,- Type ofderivative: Details of derivative,-
		N/A
		N/A
		N/A
		N/A
		N/A
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):		N/A
A statement as to whether the derivative is cash settled or physically settled:		N/A
Maturity date of the derivative (if any):		N/A
Expiry date of the derivative (if any):		N/A
The price's specified terms (if any):		N/A
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts:		N/A
For that derivative relevant interest,-		N/A
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:		N/A

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer:

Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:

==> picture [75 x 17] intentionally omitted <==

==> picture [144 x 32] intentionally omitted <==

----- Start of picture text -----

27-Sep-16
Janelle Cain, General Counsel, EBOS Group
Limited
----- End of picture text -----